TAMPA — South Carolina guard MiLaysia Fulwiley felt calmer a year ago when she experienced her first Final Four. Call it blissful ignorance. The Gamecocks were without a doubt the best team in ...

The Department of Public Health was created last year, and Gov. Henry McMaster nominated Simmer, a retired U.S. Navy ...

The Final Four is here. Coach Dawn Staley’s South Carolina women’s basketball team is playing Texas on Friday night in Tampa for a spot in Sunday’s national championship game. The State’s ...

South Carolina women's basketball guard MiLaysia Fulwiley once again showed off her show game in the Gamecocks' Final Four win over Texas on Friday. So it was only fitting that Steph Curry ...

And GSK’s first-to-market Arexvy lived up to that expectation with $1.5 billion sales in its first year of commercialization. Related As RSV vaccine clash kicks off, GSK sues Pfizer for patent ...

The South Carolina Gamecocks women's basketball team is walking into Friday night's Final Four game with two wins and one loss against Texas. But if they beat the Longhorns, they will then face a ...

In the first photo, Hudson showed a University of North Carolina jersey with her name "Jordon" — perhaps a fun nod to UNC star alum Michael Jordan — and "24" printed on it. In the corner ...

In an early chapter of South of Midnight, our protagonist Hazel is coming to grips with her newfound powers - it’s an important tone-setter, because it’s representative of what developer ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya. The shot protects ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

WLTX 19+ features the latest breaking news and weather, plus daily talk shows, coverage of your favorite sports teams from Locked On, fact-checking from VERIFY and the latest trending stories from ...